87707-83-3

Upstream product

• 109-01-3 1-methyl-piperazine 
• 87707-80-0 Toluene-4-sulfonic acid (2S,3S)-2-(3-chloro-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-ylmethyl ester 
• 6768-21-4 diethyl m-chlorobenzylidenemalonate 
• 87707-72-0 (2S,3S)-2-(3-Chloro-phenyl)-3-hydroxymethyl-2,3-dihydro-5H-benzo[b][1,4]thiazepin-4-one 
• 87707-66-2 (2R,3S)-2-(3-Chloro-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepine-3-carboxylic acid ethyl ester 
• 87707-93-5 2-[(2-Amino-phenylsulfanyl)-(3-chloro-phenyl)-methyl]-malonic acid diethyl ester 
• 15725-33-4 diethyl m-methylbenzylidenemalonate 
• 137-07-5 2-amino-benzenethiol 

Relevant academic research and scientific papers

Synthesis of a new potent anti-ulcer and gastric secretory inhibiting agent, (-)-cis-2,3-dihidro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5-benzothiaze pin-4(5H)-one hydrochloride (BTM-1086), and related compounds

(-)-cis-2,3-Dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5-benzothiazepin-4(5H)-one hydrochloride (BTM-1086) and its analogues, which possessed potent anti-ulcer and gastric secretory inhibiting activities, were synthesized and the structure of these compounds were established on the basis of spectral and chemical evidences.